Table 3.
Correlation between MMP-9 and CCR7 expression with clinicopathological features of LSCC
| Variables | N (%) | MMP-9 | P | CCR7 | P | ||
|---|---|---|---|---|---|---|---|
| High (n=33) | Low (n=27) | High (n=36) | Low (n=24) | ||||
| Gender | |||||||
| Male | 56 (93.3%) | 30 (90.9%) | 26 (96.3%) | 0.405 | 33 (91.7%) | 23 (95.8%) | 0.526 |
| Female | 4 (6.7%) | 3 (9.1%) | 1 (3.7%) | 3 (8.3%) | 1 (4.2%) | ||
| Age | |||||||
| < 50 years | 11 (18.3%) | 6 (18.2%) | 5 (18.5%) | 0.360 | 8 (22.2%) | 3 (12.5%) | 0.159 |
| 50-59 years | 17 (28.3%) | 7 (21.2%) | 10 (37%) | 7 (19.4%) | 10 (41.7%) | ||
| > 60 Years | 32 (53.3%) | 20 (60.6%) | 12 (44.4%) | 21 (58.3%) | 11 (45.8%) | ||
| Tumor Size | |||||||
| < 4 cm | 36 (60%) | 14 (42.4%) | 22 (81.5%) | 0.002* | 15 (41.7%) | 21 (87.5%) | <0.001* |
| > 4 cm | 24 (40%) | 19 (57.6%) | 5 (18.5%) | 21 (58.3%) | 3 (12.5%) | ||
| Tumor differentiation | |||||||
| Well | 13 (21.7%) | 4 (12.1%) | 9 (33.3%) | 0.047 | 6 (16.7%) | 7 (29.2%) | 0.250 |
| Moderate-Poor | 47 (78.3%) | 29 (87.9%) | 18 (66.7%) | ||||
| Lymphovascular invasion | |||||||
| Yes | 6 (10%) | 3 (9.1%) | 3 (11.1%) | 0.795 | 4 (11.1%) | 2 (8.3%) | 0.725 |
| No | 54 (90%) | 30 (90.9%) | 24 (88.9%) | 32 (88.9%) | 22 (91.7%) | ||
| pT Stage | |||||||
| 1-2 | 5 (8.3%) | 2 (6.1%) | 3 (11.1%) | 0.481 | 2 (5.6%) | 3 (12.5%) | 0.340 |
| 3-4 | 55 (91.7%) | 31 (93.9%) | 24 (88.9%) | 34 (94.4%) | 24 (87.5%) | ||
* Significant value (P< 0.05)